Novosound earns patent for wearable ultrasound that monitors blood pressure

Scottish health tech company Novosound has secured a patent for its ultrasonic instrumentation system, marking its 21st patent since 2018. 

The patent is for a wearable ultrasound, strapped onto the body to produce images on mobile devices, such as tablets and smartphones. In the patented use case, the device is secured to a patient for constant monitoring of blood flow and pressure.

Earning the patent allows Novosound to engage in research and development contracts for consumer digital health applications The patent also grants the company exclusive rights to sell the technology while continuing research and pilot projects with major tech companies and healthcare institutions. 

In a statement, Novosound says it is partnering with the Texas Medical Center to further develop use cases and improvements for its ultrasound wearables.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup